IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 3.065
+0.040 (1.32%)
Aug 22, 2025, 5:29 PM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 259.91 million as of August 29, 2025. Its market cap has decreased by -67.67% in one year.
Market Cap
259.91M
Enterprise Value
282.02M
Revenue
75.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.07
Market Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 259.91M, a decrease of -37.07%. That is a compound annual growth rate of -5.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 259.91M | -53.39% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | 2.17B | 37.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 101.89B |
| Sectra AB | 64.55B |
| Getinge AB | 56.16B |
| Camurus AB | 43.17B |
| Medicover AB | 40.08B |
| Asker Healthcare Group AB | 38.16B |
| BioArctic AB | 27.36B |
| AddLife AB | 21.53B |